Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Heuck

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|October 15, 2010
mTOR-inhibition in metastatic renal cell carcinoma. Focus on temsirolimus: a reviewH Gerullis, T H Ecke, C Eimer, et al.
Leukemia|July 16, 2013
Hematopoietic progenitor cell collection after autologous transplant for multiple myeloma: low platelet count predicts for poor collection and sole use of resulting graft enhances risk of myelodysplasiaX Papanikolaou, E R Rosenbaum, L N Tyler, et al.
Leukemia|November 4, 2015
Clinical value of molecular subtyping multiple myeloma using gene expression profilingN Weinhold, C J Heuck, A Rosenthal, et al.
Leukemia|April 18, 2012
Primary plasma cell leukemia: clinical and laboratory presentation, gene-expression profiling and clinical outcome with Total Therapy protocolsS Z Usmani, B Nair, P Qu, et al.
Blood Cancer Journal|July 30, 2016
Dose-dense and less dose-intense Total Therapy 5 for gene expression profiling-defined high-risk multiple myelomaY Jethava, A Mitchell, M Zangari, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|October 15, 2010
mTOR-inhibition in metastatic renal cell carcinoma. Focus on temsirolimus: a reviewH Gerullis, T H Ecke, C Eimer, et al.
Leukemia|July 16, 2013
Hematopoietic progenitor cell collection after autologous transplant for multiple myeloma: low platelet count predicts for poor collection and sole use of resulting graft enhances risk of myelodysplasiaX Papanikolaou, E R Rosenbaum, L N Tyler, et al.
Leukemia|November 4, 2015
Clinical value of molecular subtyping multiple myeloma using gene expression profilingN Weinhold, C J Heuck, A Rosenthal, et al.
Leukemia|April 18, 2012
Primary plasma cell leukemia: clinical and laboratory presentation, gene-expression profiling and clinical outcome with Total Therapy protocolsS Z Usmani, B Nair, P Qu, et al.
Blood Cancer Journal|July 30, 2016
Dose-dense and less dose-intense Total Therapy 5 for gene expression profiling-defined high-risk multiple myelomaY Jethava, A Mitchell, M Zangari, et al.
Pageof 1